DLA Piper advises Helios in its majority acquisition of three MedTech companies in Morocco
DLA Piper advised Helios Investment Partners, the leading Africa-focused private equity firm in the context of its acquisition of a majority stake in a large and diversified group of MedTech companies in Morocco, comprising three entities: Techniques Science Santé (T2S), IM Alliance and Binarios. The investment will provide additional support in the group’s push to further develop itself in a rapidly growing healthcare market in Francophone Africa.
The consolidated group of companies, under the leadership of Abderraouf Sordo, has positioned itself as a leading medical equipment distributor and maintenance provider throughout French-speaking Africa. Today, it is the largest regional group in the healthcare sector, with annual revenues of over USD100 million. The group notably provides a large base of public and private healthcare facilities with access to high-end medical solutions.
Christophe Bachelet, Country Managing Partner for DLA Piper in Morocco commented: “Our cross-border team was proud to have accompanied Helios Investment Partners in what will be one of the largest private equity deals in Morocco this year. Despite the challenges the country has faced in 2021, transactions such as these led by pan-African private equity firms show the robust growth that the Kingdom of Morocco will continue to see in 2022.”
Advisor to Helios Investment Partners: DLA Piper in Casablanca, with Franck Coudert, Partner, Camilia Benani, Counsel, Ghita Moussaid, Senior Associate, Kenza Belrhiti Alaoui, Associate and Léa Attias, Associate, as well as DLA Piper in London, with Chris Baird, Partner and Emily Garland, Associate.
Advisor to the sellers: Allen & Overy
Advisor to Helios Investment Partners as borrower: Allen & Overy
Advisor to the lenders: Norton Rose Fulbright